Market Strategy 8/10/2020
Nothing Comes Easy
Even as progress is made on a number of fronts significant challenges remain
Key Takeaways
- With stocks just shy (1.04%) of their February 19 peak, investors this week will pay close attention to economic data, earnings results, and any developments on the Covid-19 front.
- At current levels, the equity market appears vulnerable to any catalysts that could justify near-term profit taking without FOMO.
- In our view the level of 3,500 on the S&P 500 could be reached and possibly exceeded this year before earnings growth projections could justify the move on traditional P/E metrics.
- With 89% of companies in the S&P 500 index having reported results for Q2, about 80% have beaten expectations.
- Last week’s employment report exceeded analyst forecasts, providing further evidence of the resilience of the US economy.
No lack of challenges on the landscape likely points to opportunities for investors willing to contend with uncertainties including those that lie ahead tied to the process of addressing the Covid-19 crisis and the US presidential election.
The current environment reminds us that anybody who thinks that successful investing is an easy game or a walk in the park will inevitably be proven wrong. Like life investing has its ups and downs and could try the patience of a saint. That said many find the process of living life and investing rewarding.
Political wrangling and gridlock in Washington, DC over a fourth rescue program that stretched into the weekend has prompted the President to move according to the news closer toward taking executive action to bridge the gap to provide rescue funding. Such prospective effort should likely provide impetus for Congress to find a way to agreement and a broader solution sooner than later.
As of early evening on Sunday as we prepared to publish, Bloomberg News reported that cases of Covid-19 had reached over 19.6 million worldwide with deaths totaling some 727,000. The positive-test rate in the US had risen to 5 million infections.
With more than 160 vaccines to combat Covid-19 now under development across the globe—including 14 candidate vaccines in the US government’s Operation Warp Speed program that aims to deliver 300 million doses by January, 2021— news of positive developments crosses the proverbial transom on almost a daily basis. The news is providing hope for communities around the world, boosting prospects for a global economic recovery in the not too distant future and providing lift to stocks stateside and abroad.
In large part equity markets in the US and around the world are reflecting expectations that the efforts of scientists around the globe will arrive at the development of a vaccine (or a number of them) that will safely and effectively be able to stem the spread of the virus and enable countries around the world to move forward with re-openings of their respective economies with greater levels of confidence.
With today’s state of the art technology and scientific processes pressed into action in a worldwide effort to find a positive solution to stem the virus’ spread and toll, expectations for success may prove reasonable and correct. The immediate challenge for public and investor sentiment will be the impediments and hurdles to be traversed along the way to success.
The S&P 500 Climbs Wall of Worry
For all the attention the S&P 500’s significant rally from the low on March 23rd (up 49.8% through last Friday) has received, recent gains in the benchmark have been in aggregate moderate since the end of the first week in June. From June 8 through last Friday’s close the benchmark is up just 3.7% suggesting that the market has not so much been taken hostage by animal spirits and irrational exuberance (as the action in some individual stocks might suggest) but rather that investors and traders have been practicing rebalancing and rotation among cyclicals and defensive sectors as well as among market capitalization segments that could lead to a broadening of the rally.
The S&P 500 has closed higher on-the-week in six of the past nine weeks beginning with the week that started on June 8. This occurred in a period that has seen among other things: a resurgence of Covid-19 that has challenged the process of economic re-openings in a large number of US states; a deterioration in geopolitics and domestic politics; concerns about the risks of not extending government economic rescue programs; as well as worries about potential negative longer-term effects from the current magnanimously accommodative Federal Reserve monetary policy.
These negatives and concerns have been in our view offset by a number of positives including: progress with vaccines being tested; news about drugs of greater efficacy to treat those falling ill from infection; economic data (that while not necessarily robust) illustrates the resilience and strengths of the US economy in a period of unprecedented challenges; and a significant percentage of companies (81%) beating analyst estimates in the S&P 500’s earnings season for Q2 2020.
Where We Stand
In our view diversification, patience, self-knowledge, right-sized expectations, and keeping things in context remain key factors for investors in positioning their portfolios and navigating market conditions. We remain diversified in our investment portfolios; maintain an overweight in equities versus fixed income; and favor cyclical sectors over defensive sectors. Our favorite sectors remain: information technology, consumer discretionary, industrials, and our contrarian pick: financials.
From a global perspective we remain overweight US equities while maintaining meaningful exposure to both developed and emerging markets on expectations that an economic recovery stateside coming out of the Covid-19 shutdown will help boost economic growth around the world and lead to a global economic expansion (similar to the one the world was experiencing just prior to the trade war between the US and China).
We believe stocks at current levels remain vulnerable to catalysts that might surface near term which could enable short term and nervous investors, as well as traders, to take some profits without FOMO (fear of missing out). A pull back of 4% to 6% could take place should such a catalyst appear. We are reminded that stocks tend not to move in a straight line higher unchallenged for long. However, such a pullback (depending on the catalyst for profit taking) could likely present an opportunity to buy “babies that get thrown out with the bathwater.”
Our 2020 target price of 3,500 for the S&P 500 (initiated last December) remains in suspension (suspended the morning of March 23rd) at this time while we await earnings visibility to improve further.
The market’s persistent strength and resilience notwithstanding the challenges that remain in place tell us that the level of 3,500 for the S&P 500 could be reached and possibly exceeded this year before earnings growth projections can justify such a move on traditional and historic price to earnings metrics.
This report is issued and approved by Oppenheimer & Co. Inc., a member of all Principal Exchanges, and SIPC. This report is distributed by Oppenheimer & Co. Inc., for informational purposes only, to its institutional and retail investor clients. This report does not constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited. The securities mentioned in this report may not be suitable for all types of investors. This report does not take into account the investment objectives, financial situation or specific needs of any particular client of Oppenheimer & Co. Inc. Recipients should consider this report as only a single factor in making an investment decision and should not rely solely on investment recommendations contained herein, if any, as a substitution for the exercise of independent judgment of the merits and risks of investments. The strategist writing this report is not a person or company with actual, implied or apparent authority to act on behalf of any issuer mentioned in the report. Before making an investment decision with respect to any security discussed in this report, the recipient should consider whether such investment is appropriate given the recipient's particular investment needs, objectives and financial circumstances. We recommend that investors independently evaluate particular investments and strategies, and encourage investors to seek the advice of a financial advisor. Oppenheimer & Co. Inc. will not treat non-client recipients as its clients solely by virtue of their receiving this report. Past performance is not a guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance of any security mentioned in this report. The price of the securities mentioned in this report and the income they produce may fluctuate and/or be adversely affected by exchange rates, and investors may realize losses on investments in such securities, including the loss of investment principal.
Oppenheimer & Co. Inc. accepts no liability for any loss arising from the use of information contained in this report. All information, opinions and statistical data contained in this report were obtained or derived from public sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such information, opinion or statistical data is accurate or complete and they should not be relied upon as such. All estimates and opinions expressed herein constitute judgments as of the date of this report and are subject to change without notice. Nothing in this report constitutes legal, accounting or tax advice. Since the levels and bases of taxation can change, any reference in this report to the impact of taxation.
Investment Strategy should not be construed as offering tax advice on the tax consequences of investments. As with any investment having potential tax implications, clients should consult with their own independent tax adviser.
This report may provide addresses of, or contain hyperlinks to, Internet web sites. Oppenheimer & Co. Inc. has not reviewed the linked Internet web site of any third party and takes no responsibility for the contents thereof. Each such address or hyperlink is provided solely for the recipient's convenience and information, and the content of linked third party web sites is not in any way incorporated into this document. Recipients who choose to access such third-party web sites or follow such hyperlinks do so at their own risk. The S&P 500 Index is an unmanaged value-weighted index of 500 common stocks that is generally considered representative of the U.S. stock market. The S&P 500 index figures do not reflect any fees, expenses or taxes. This research is distributed in the UK and elsewhere throughout Europe, as third party research by Oppenheimer Europe Ltd, which is authorized and regulated by the Financial Conduct Authority (FCA). This research is for information purposes only and is not to be construed as a solicitation or an offer to purchase or sell investments or related financial instruments. This report is for distribution only to persons who are eligible counterparties or professional clients and is exempt from the general restrictions in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds that it is being distributed in the UK only to persons of a kind described in Article 19(5) (Investment Professionals) and 49(2) High Net Worth companies, unincorporated associations etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended). It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. In particular, this material is not for distribution to, and should not be relied upon by, retail clients, as defined under the rules of the FCA. Neither the FCA’s protection rules nor compensation scheme may be applied. This report or any portion hereof may not be reprinted, sold, or redistributed without the written consent of Oppenheimer & Co. Inc. Copyright © Oppenheimer & Co. Inc. 2020.